Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
126 studies found for:    "Lip and oral cavity cancer"
Show Display Options
RSS Create an RSS feed from your search for:
"Lip and oral cavity cancer"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma;   Salivary Gland Squamous Cell Carcinoma;   Stage 0 Hypopharyngeal Cancer;   Stage 0 Laryngeal Cancer;   Stage 0 Lip and Oral Cavity Cancer;   Stage 0 Nasopharyngeal Cancer;   Stage 0 Oropharyngeal Cancer;   Stage 0 Paranasal Sinus and Nasal Cavity Cancer;   Stage I Salivary Gland Cancer;   Stage I Squamous Cell Carcinoma of the Hypopharynx;   Stage I Squamous Cell Carcinoma of the Larynx;   Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage I Squamous Cell Carcinoma of the Nasopharynx;   Stage I Squamous Cell Carcinoma of the Oropharynx;   Stage I Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage I Verrucous Carcinoma of the Larynx;   Stage I Verrucous Carcinoma of the Oral Cavity;   Stage II Salivary Gland Cancer;   Stage II Squamous Cell Carcinoma of the Hypopharynx;   Stage II Squamous Cell Carcinoma of the Larynx;   Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage II Squamous Cell Carcinoma of the Nasopharynx;   Stage II Squamous Cell Carcinoma of the Oropharynx;   Stage II Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage II Verrucous Carcinoma of the Larynx;   Stage II Verrucous Carcinoma of the Oral Cavity;   Stage III Salivary Gland Cancer;   Stage III Squamous Cell Carcinoma of the Hypopharynx;   Stage III Squamous Cell Carcinoma of the Larynx;   Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage III Squamous Cell Carcinoma of the Nasopharynx;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage III Verrucous Carcinoma of the Larynx;   Stage III Verrucous Carcinoma of the Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IVA Salivary Gland Cancer;   Stage IVA Squamous Cell Carcinoma of the Larynx;   Stage IVA Oral Cavity Squamous Cell Carcinoma;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Nasal Cavity and Paranasal Sinus Cancer;   Stage IVA Verrucous Carcinoma of the Larynx;   Stage IVA Verrucous Carcinoma of the Oral Cavity;   Stage IVB Salivary Gland Cancer;   Stage IVB Squamous Cell Carcinoma of the Larynx;   Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVB Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Oral Cavity Squamous Cell Carcinoma;   Stage IVB Verrucous Carcinoma of the Larynx;   Stage IVB Verrucous Carcinoma of the Oral Cavity;   Stage IVC Salivary Gland Cancer;   Stage IVC Squamous Cell Carcinoma of the Larynx;   Stage IVC Oral Cavity Squamous Cell Carcinoma;   Stage IVC Squamous Cell Carcinoma of the Oropharynx;   Paranasal Sinus and Nasal Cavity Squamous Cell Carcinoma;   Stage IVC Verrucous Carcinoma of the Larynx;   Stage IVC Verrucous Carcinoma of the Oral Cavity;   Tongue Cancer
Interventions: Other: placebo;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Drug: chemoprevention
2 Active, not recruiting Erlotinib Prevention of Oral Cancer (EPOC)
Condition: Oral Cancer
Interventions: Drug: Erlotinib;   Drug: Placebo
3 Completed Workplace Tobacco Cessation And Oral Cancer Screening Study
Conditions: Tobacco Cessation;   Oral Cancer
Intervention: Behavioral: Behavioural and Pharmacotherapy for tobacco cessation
4 Unknown  Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions
Condition: Oral Cancer
Intervention:
5 Recruiting Validation of DNA Methylation Biomarkers for Oral Cancer Detection
Condition: Oral Cancer
Intervention:
6 Recruiting Study on the Carcinogenesis of Gα12 in Oral Cancer, and the Treatment of Oral Cancer Using Ga12 Inhibitor.
Conditions: Carcinogenesis;   Oral Cancer
Intervention:
7 Recruiting Analysis Of Sensory Recovery Of Donor Size And Quality Life In Oral Cancer Patients
Condition: Oral Cancer
Intervention:
8 Recruiting Study on the Carcinogenesis of SOX-9 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer.
Conditions: Carcinogenesis;   Oral Cancer
Intervention:
9 Completed Biomarkers for Oral Cancer
Condition: Oral Cancer
Intervention:
10 Active, not recruiting Web-based Education on Oral Cancer for Primary Care Physicians in Ohio
Condition: Oral Cancer
Intervention: Other: Web-based Educational Intervention
11 Unknown  PET/CT and Sentinel Node in Oral Cancer
Condition: Oral Cancer
Intervention:
12 Unknown  Oral Cancer Screening in Mumbai, India by Primary Health Care Workers
Conditions: Oral Cancer;   Precancerous Conditions
Interventions: Other: Unaided Visual Inspection;   Device: VelScope;   Other: Toluidine Blue Assisted Oral Examination
13 Completed Behavior Change on Oral Cancer Patients After a Localized Behavior Change Model Intervention
Condition: Oral Cancer
Interventions: Behavioral: smoking cessation program;   Behavioral: Lifestyle counseling
14 Recruiting Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care
Conditions: Lip and Oral Cavity Squamous Cell Carcinoma;   Oral Cavity Verrucous Carcinoma;   Stage 0 Lip and Oral Cavity Cancer;   Tongue Cancer
Interventions: Procedure: fluorescence imaging;   Procedure: biopsy;   Procedure: examination;   Procedure: Comparison of surgical margins by COE vs. DVFE
15 Unknown  Epstein-Barr Detection in Oral Cancer
Condition: Oral Cancer
Intervention:
16 Recruiting Efficacy of Optically-guided Surgery in the Management of Early-staged Oral Cancer - COOLS TRIAL
Conditions: Oral Cancer;   High-grade Precancer
Intervention: Procedure: Fluorescence visualization device
17 Completed Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx
Conditions: Lip and Oral Cavity Cancer;   Oropharyngeal Cancer;   Stage 0 Lip and Oral Cavity Cancer;   Stage 0 Oropharyngeal Cancer;   Tongue Cancer
Interventions: Biological: Ad5CMV-p53 gene;   Other: laboratory biomarker analysis
18 Withdrawn ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer
Conditions: Lip and Oral Cavity Cancer;   Head and Neck Cancer;   Oropharyngeal Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: ONYX-015
19 Active, not recruiting Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
Conditions: Locally Advanced Malignant Neoplasm;   Oral Cancer;   Oropharyngeal Carcinoma
Intervention: Drug: Neo-adjuvant Erbitux-based chemotherapy
20 Recruiting Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
Conditions: Locally Advanced Malignant Neoplasm;   Oral Cancer;   Oropharyngeal Carcinoma;   Effects of Chemotherapy
Intervention: Drug: Neo-adjuvant Erbitux-based chemotherapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years